Mol. Cells

A Molecular Approach to Mitophagy and Mitochondrial Dynamics

Seung-Min Yoo, and Yong-Keun Jung

Additional article information


Mitochondrial quality control systems are essential for the maintenance of functional mitochondria. At the organelle level, they include mitochondrial biogenesis, fusion and fission, to compensate for mitochondrial function, and mitophagy, for degrading damaged mitochondria. Specifically, in mitophagy, the target mitochondria are recognized by the autophagosomes and delivered to the lysosome for degradation. In this review, we describe the mechanisms of mitophagy and the factors that play an important role in this process. In particular, we focus on the roles of mitophagy adapters and receptors in the recognition of damaged mitochondria by autophagosomes. In addition, we also address a functional association of mitophagy with mitochondrial dynamics through the interaction of mitophagy adaptor and receptor proteins with mitochondrial fusion and fission proteins.

Keywords: autophagy, mitochondria, mitochondrial quality control, mitophagy, selective autophagy


Mitochondria are the main site of adenosine triphosphate (ATP) synthesis. Mitochondria are also crucial in apoptosis, necrosis, autophagy, stress regulation, production of lipids and carbohydrates, Ca2+ storage and innate immunity (Galluzzi et al., 2012). Therefore, mitochondrial dysfunction is associated with many diseases (Suomalainen and Battersby, 2017). Mitochondria undergo constant turnover and their half-life varies from tissue to tissue (Gottlieb and Stotland, 2015). Mitochondria are exposed to damages caused by intra- and extra-mitochondrial events, such as mutated mitochondrial proteins and reactive oxygen species (ROS) (Galluzzi et al., 2012). Mitochondrial quality control systems actively function, both in physiological and pathological conditions, to protect the mitochondria from stress and damage at the protein and organelle level. Damage beyond the protein level activates a bigger response that includes mitochondrial biogenesis, fusion, fission and mitochondrial degradation, also known as mitophagy. In this review, we will focus on recent data regarding the molecular mechanisms of mitochondrial quality control, especially in relation to mitophagy, and describe how these mechanisms can affect each other.


Mitochondria first respond to stress by attempting to maintain their structure and composition. This is achieved through the action of antioxidants, DNA repair, protein folding and degradation. Mitochondrial DNA is highly exposed to oxidative damage due to the production of ROS during oxidative phosphorylation. DNA damage is repaired by mitochondrial DNA polymerase gamma (encoded by POLG) that has base excision repair and exonuclease function. Mutation of POLG causes neurodegeneration, progressing into Leigh or Alpers-Huttenlocher syndrome (Scheibye-Knudsen et al., 2015). Antioxidants, such as superoxide dismutase, catalase, glutathione peroxidase/glutathione, peroxiredoxins and vitamin E/C, directly protect mitochondria by reducing reactive intermediates (Scheibye-Knudsen et al., 2015). In addition, mitochondrial chaperones, such as heat shock protein (Hsp)60 and Hsp70, import nuclear-encoded mitochondrial proteins (NEMP) into the mitochondrial matrix and refold misfolded proteins (Hammerling and Gustafsson, 2014). When misfolded or damaged proteins accumulate, the proteases LON and ClpP, in the matrix, and ATPase associated with diverse cellular activities (AAA), in the membrane, degrade them to maintain normal mitochondria(Cenini and Voos, 2016). Proteins in the outer mitochondrial membrane are ubiquitinated by the E3 ligase MARCH5, and targeted for degradation to the 26S proteasome (Bragoszewski et al., 2017). If the damage is beyond the capacity of these systems, a broader quality control system is activated.

At the organelle level, mitochondria quality is sustained through synthesis of new mitochondria, fusion and fission, and elimination of the damaged ones. Mitochondrial biogenesis requires the delivery of NEMP to the mitochondria and is induced by endogenous (e.g. ROS, nitrogen oxide, carbon monoxide, and H2S), and external signals (e.g. estrogen), which increase the amount of NEMP through nuclear respiration factor-1 (NRF1), peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and estrogen receptor. Calorie restriction and exercise also stimulate mitochondrial biogenesis through changes in the ratio of oxidized/reduced nicotinamide adenine dinucleotide (NAD+/NADH) and adenosine mono-phosphate (AMP)/ATP, and increase NEMP levels via sirtuins (SIRT) and AMP-activated protein kinase (AMPK) pathways (Suliman and Piantadosi, 2016).

Compared to other organelles, mitochondria frequently change their shape under physiologic and pathologic conditions. Specifically, mitochondrial dynamics (fusion and fission) regulates mitochondrial network connectivity, which depends on the specific metabolic needs of the cell (Miettinen and Björklund, 2017; Rambold and Pearce, 2017). The processes controlling mitochondria dynamics are well understood and mediated by specific proteins. Mitochondrial outer membrane fusion is induced by MitoPLD, a member of the phospholipase D family, which converts cardiolipin into phosphatidic acid, and by homo or hetero dimerization of the guanosine triphosphate hydrolases (GTPases) mitofusin (MFN) 1 and 2. In addition to outer membrane, fusion of the mitochondrial inner membrane requires optic atrophy 1 (OPA1), anchored in the inner membrane and exposed to the intermembrane space. On the other hand, mitochondrial fission occurs when the GTPase dynamin related protein-1 (Drp1) translocates to the mitochondrial outer membrane to bind its receptors, such as FIS1, MFF, MID49 and MID51, and forms a multimeric structure around the fission site of the mitochondrion. While the precise reason is not yet clarified, mitochondrial protein 18 kDa (MTP18) gene ablation induces fusion of mitochondria and expression of cleaved OPA1 (S-OPA1) induces fission (Wai and Langer, 2016). Through mechanisms not fully understood, mitochondrial dynamics is also engaged in the repair of a part of the damaged mitochondria. If the mitochondria cannot be restored to a healthy state through these processes, they are eliminated by selective autophagy.


Autophagy, a lysosome-dependent degradation, is categorized into macroautophagy, microautophagy and chaperone-mediated-autophagy (CMA). Macroautophagy is characterized by the formation of an autophagosome: the phosphatidylinositol 3-kinase (PI3K) class III produces phosphatidylinositol 3-phosphate (PI3P) and induces the formation of the isolation membrane (phagophore), which progressively expands by using two-ubiquitin-like systems till the formation of a double-membrane vesicle (the autophagosome). Cytoplasmic cargos are sequestered into the autophagosome and subsequently degraded through the lysosomes. In microautophagy, cytosolic cargo is directly engulfed by lysosomes while CMA selectively recruits target proteins into the lysosomes through chaperone proteins without autophagosome formation (Nah et al., 2015).

Unlike non-selective removals of various targets by macroautophagy, targets ranging from proteins to organelles, including aggregated proteins, mitochondria, endoplasmic reticulum, peroxisomes, invaded bacteria, viruses and membranes, are often degraded by selective autophagy (Galluzzi et al., 2017). Among them, mitophagy is the selective removal of mitochondria via autophagy. Then, an important question is how mitochondria are selectively recognized and removed. A report shows that mitochondria-derived vesicles are directly degraded to lysosomes (Lemasters, 2014). Most of the studies, however, have focused on autophagosome-mediated mitophagy and on the importance of mitophagy mediators that interact with LC3. Recently, many studies have investigated the mechanisms of this process. Details on mitophagy are discussed below.


Ubiquitin-mediated interaction of LC3 adapters

In this pathway, the first event is the ubiquitination of mitochondrial substrates, which are then recognized by LC3 adapters.

PINK1/Parkin pathway

Depolarization of the mitochondrial membrane due to damage, reduces the cleavage of PINK1. PINK1 accumulates on the mitochondrial outer membrane through the translocase of the outer membrane (TOM). Mitochondrial pyruvate level can also affect the accumulation of PINK1 by inducing the interaction between PINK1 and TOM (Park et al., 2015). Accumulated PINK1 is autophosphorylated and activated, and phosphorylates ubiquitin on serine 65 (Ser65), which recruits Parkin. On the mitochondrial membrane, Parkin is phosphorylated and activated by PINK1, and polyubiquitinates its substrates (Nguyen et al., 2016). Specifically, the polyubiquitination of Parkin substrates, such as voltage-dependent anion channel-1 (VDAC1), MFN 1/2 and Miro 1, leads to their degradation by the proteasome (Chan et al., 2011; Tanaka et al., 2010). The degradation of MFN 1/2 induces mitochondrial fission and mitophagy (Tanaka et al., 2010), linking mitochondrial dynamics to mitophagy.

LC3 adapters: p62, OPTN, NDP52, TAX1BP1 and NBR1

Recently, a Parkin-independent role of PINK1 in mitophagy has been uncovered. In this pathway, PINK1 recruits OPTN and NDP52 on the mitochondria, which subsequently recruit autophagy initiation factors, such as ULK1, double FYVE-containing protein 1 (DFCP1) and WD repeat domain phosphoinositide-interacting protein 1 (WIPI1) (Lazarou et al., 2015). In addition, overexpressed synphilin-1, a synuclein alpha-interacting protein, interacts with PINK1 and induces its accumulation. The PINK1-synphilin1 complex recruits seven in absentia homolog-1 (SIAH-1), an E3 ubiquitin ligase, to increase mitochondrial ubiquitination (Szargel et al., 2016), indicating that E3 ligases other than Parkin target the mitochondria for degradation in different ways.

Ubiquitin-independent interaction of LC3 adapters

Damaged mitochondria can also be recognized by LC3 adapters in an ubiquitin-independent manner.

CHDH and TBC1D15

Choline dehydrogenase (CHDH) is located in the mitochondrial inner and outer membranes under normal conditions. When the mitochondrial membrane potential is disrupted, CHDH accumulates in the mitochondrial outer membrane and interacts with p62 through its Phox and Bem1 (PB1) domain, leading to the formation of the CHDH-p62-LC3 complex that mediates mitophagy (Park et al., 2014). CHDH’s role in mitophagy, shown in gene ablation experiments, is Parkin-independent. In addition, TBC1 domain family member 15 (TBC1D15), a mitochondrial Rab GTPase-activating protein (Rab-GAP), forms a complex with TBC1D17 and migrates to the mitochondrial outer membrane by interacting with mitochondrial fission 1 protein (FIS1). The TBC1D15/17 complex then interacts with LC3 (Yamano et al., 2014). These adapters sense mitochondrial damage and consequently change their subcellular location or the protein they interact with, guiding the damaged mitochondria to the autophagosome.

Interaction between LC3 and its receptors

Unlike aforementioned LC3 adapters which require additional proteins to interact with LC3, several LC3 receptors are located on the mitochondria; they directly bind to LC3 and recruit the damaged mitochondria to autophagosomes.


FUNDC1 is a mitochondrial outer membrane protein that mediates hypoxia-induced mitophagy in mammalian cells (Liu et al., 2012). FUNDC1 regulates Parkin-independent mitophagy by binding to LC3 under hypoxia. Specifically, the phosphorylation of FUNDC1 at Tyr18 by SRC and Ser13 by casein kinase II (CK2) suppresses its interaction with LC3 under normoxic conditions (Chen et al., 2014; Liu et al., 2012). Under hypoxia, FUNDC1 is dephosphorylated at Ser13 by phosphoglycerate mutase 5 (PGAM5) and phosphorylated at Ser17 by ULK1 (Chen et al., 2014). In addition, FUNDC1 is Lys119-ubiquitinated by MARCH5 and degraded in the initial phase of hypoxia; the remaining FUNDC1 participates in mitophagy under prolonged hypoxia (Chen et al., 2017). Inhibition of FUNDC1-mediated mitophagy by Receptor-interacting serine/threonine-protein kinase 3 (Ripk3), which participates in necroptosis- and mitochondria-mediated apoptosis, increases mitochondrial apoptosis in cardiac ischemia/reperfusion injury (Zhou et al., 2017). On the contrary, a report showed that knockdown or overexpression of FUNDC1 has insignificant effect on starvation- or hypoxia-induced mitophagy (Hirota et al., 2015), which remains to be clarified.

BCL2L13 and FKBP8

FK506-binding protein 8 (FKBP8), was identified as a LC3-interacting protein using yeast two-hybrid screening (Bhujabal et al., 2017). FKBP8 is located on the mitochondrial outer membrane and mediates mitophagy by interacting with LC3A (Bhujabal et al., 2017); the effect of FKBP8 on mitophagy is Parkin-independent. In particular, FKBP8 migrates from the mitochondria into the ER following the treatment with carbonyl cyanide m-chlorophenylhydrazone (CCCP), a chemical ionophore (Saita et al., 2013). Accordingly, the FKBP8 N412K mutant, which cannot be targeted to ER, plays a role in mitophagy only, suggesting that the subcellular localization of FKBP8 regulates mitophagy (Bhujabal et al., 2017).

PHB2 and cardiolipin

Cardiolipin, a membrane lipid in the mitochondrial inner membrane, can also function as a LC3 receptor in mitophagy. Cardiolipin is translocated from the inner membrane to the outer membrane in the presence of external toxic signals, such as 6-hydroxydopamine (6-OHDA), rotenone and 1-methyl-4-phenylpyridinium (MPP+). Externalized cardiolipin directly interacts with the N-terminal helices of LC3 (Chu et al., 2013). This interaction seems to be LC3 subtype-specific. In vitro experiments revealed that cardiolipin directly interacts with gamma-aminobutyric acid receptor-associated protein (GABARAP), a member of the LC3 family, but does not translocate GABARAP to the mitochondria in rotenone-treated cells, implying that cardiolipin interacts with GABARAP in different autophagic processes (Anton et al., 2016). These data indicate that mitochondrial inner membrane components also participate in mitophagy.


Changes in mitochondrial shape and size are associated to the fission and fusion of the mitochondria according to the cell’s needs (Trotta and Chipuk, 2017). Since the size of the autophagosome in mammalian cells is approximately 500–1500 nm (Wang and Klionsky, 2003), it is reasonable to predict that a huge mitochondria network should be fragmented through fission prior to mitophagy. In that regard, it has been reported that either mitochondrial fission-related factors or degradation of mitochondrial fusion-related factors are required for mitophagy (Shirihai et al., 2015). Proteins with a role in mitochondrial dynamics are thus implicated in mitophagy to function together with the aforementioned LC3 adapters/receptors. That is, Drp1, a mitochondrial fission protein, interacts with over-expressed FUNDC1 and BCL2L13, and both FUNDC1 and BNIP3 require Drp1 for mitochondrial fragmentation and Parkin-mediated mitophagy (Lee et al., 2011; Wu et al., 2016). In contrast, a recent report showed that mitophagy occurs without mitochondrial fission (Yamashita and Kanki, 2017). Thus, the role of Drp1 in mitophagy needs to be further addressed.

In addition, OPA1, a mitochondrial fusion protein, may also play a role as a mitophagic factor. BNIP3 induces mitochondrial fragmentation through its interaction with OPA1 (Landes et al., 2010). Ablation of PHB2 leads to loss of OPA1 long isoform, resulting in an abnormal cristae morphogenesis and mitochondrial fragmentation (Merkwirth et al., 2008). A recent report has shown that the fusion of the inner membrane of the mitochondria requires the binding of OPA1 with cardiolipin and high concentration of cardiolipin in the inner membrane (Ban et al., 2017). Additionally, TBC1D15 mediates the autophagic encapsulation of mitochondria downstream of Parkin activation, upon interaction with FIS1 (Yamano et al., 2014). Thus, it is likely that mitophagy is functionally associated with mitochondrial dynamics, through the interaction between mitochondrial dynamics factors and LC3 adapter/receptors. The details of the interplay between mitochondrial dynamics and mitophagy remain, however, to be further assessed.


To understand the molecular mechanism of mitophagy, CCCP has widely been used to disrupt the membrane potential of the mitochondria and induce mitophagy, in vitro. Despite its great contribution to the elucidation of mitophagy, the conditions it creates are different from physiologic conditions. Mitophagy constantly occurs in basal conditions (Bingol et al., 2014) and is induced under specific physiological conditions. During development, NIX is responsible for the removal of mitochondria from maturing erythrocytes (Sandoval et al., 2008), and Parkin and mitochondrial E3 ubiquitin protein ligase 1 (MUL1) are required for degradation of paternal mitochondria after fertilization in mice (Rojansky et al., 2016). Mitophagy is also involved in cellular differentiation. PINK1-dependent mitophagy affects pluripotency and differentiation state in stem cells (Vazquez-Martin et al., 2016). Mitophagy appears to contribute to metabolic changes in the differentiation of retinal ganglion cells (Esteban-Martinez et al., 2017) and the transition from beige to white adipocytes (Wrighton, 2016). In addition, mitophagy plays a role in the activation of the NOD-like receptor protein 3 (NLRP3) inflammasome (Lazarou, 2015) and FUNDC1-dependent mitophagy decreases the activation of platelet following acute ischemia/reperfusion injury (Zhang et al., 2016). Together, these reports show diverse roles of mitophagy in development and cell differentiation.


A dysfunction in the mitochondria quality control and/or mitophagy is associated with many pathological conditions: one of the most studied examples are some neurodegenerative diseases (Rodolfo et al., 2017). Parkin and PINK1 are genetic factors in Parkinson’s disease and play a protective role in neurons through mitophagy (Ashrafi et al., 2014). In Alzheimer disease progression, Parkin is involved in the removal of mitochondria (Ye et al., 2015) and its overexpression alleviates the symptoms of the disease (Martin-Maestro et al., 2016). In Huntington’s disease, mitophagy is altered. Mutant huntingtin acts as a scaffold inducing selective autophagy (Martinez-Vicente et al., 2010) or negatively affecting mitochondrial delivery to the lysosome (Wong and Holzbaur, 2014). The details of this process are unclear. Mitochondrial dysfunction is also observed in amyotrophic lateral sclerosis (ALS), though the role of autophagy in this disease is uncertain (Rodolfo et al., 2017). Mutant superoxide dismutase-1 (SOD1), involved in ALS, induces mitochondrial fragmentation and inhibits mitochondrial retrograde axonal transport (Magrane et al., 2014). In addition, mutant SOD1 binds to p62, OPTN and LC3 (Rodolfo et al., 2017). Thus, reduced targeting of ubiquitinated mitochondria to autophagosomes might contribute to ALS pathology.

Mitophagy is also associated with cancer (Drake et al., 2017). Metabolic-reprogramming in cancer cells is associated with decreased mitophagy and increased mitochondrial biogenesis (Vazquez et al., 2013) and inhibition of mitophagy reduces cell stemness in cell self-renewal (Drake et al., 2017). In relation to inflammation-induced cell death, p62-mediated elimination of damaged mitochondria attenuates inflammation by reducing NLRP3 inflammasome activation in macrophages (Zhong et al., 2016). When DNA is damaged, mitophagy is induced through the poly (ADP-ribose) polymerase-1 (PARP1)-SIRT1-BNIP3/NIX pathway to limit the generation of ROS or inflammasomes, which are harmful to the cell (Drake et al., 2017). In cardiovascular diseases, mitophagy factors are either protective or damaging. It was shown that Parkin and PGAM5 prevent cardiac damage, while FUNDC1, MFN1 and MFN2 in the absence of BNIP3 have an opposite effect. Additionally, Parkin and PINK1 have a protective role in atherosclerosis (Bravo-San Pedro et al., 2017). Likewise, the role of mitophagy in lung disease is not clear. The absence of PINK1 has a protective effect on mitophagy-dependent necroptosis in chronic obstructive pulmonary disease (COPD) (Mizumura et al., 2014), but also induces idiopathic pulmonary fibrosis (IPF). Mitophagy reduces mitochondrial ROS, which modulate senescence in human bronchial epithelial cells. Thus, the role of mitophagy in lung disease depends on the cell type (Cloonan and Choi, 2016).

In acute kidney injury, mitochondrial dysfunction precedes renal dysfunction. Mitophagy protects renal cells against damage in acute kidney injury and metabolic acidosis, a cause of chronic kidney disease. A high-calorie diet causes renal injury, reduces autophagy and mitophagy, and is associated with abnormal mitochondrial morphology (Parikh et al., 2015). Mitophagy also affects non-alcoholic fatty liver disease (NAFLD); NAFLD is relieved by the thyroid hormone (TH), which stimulates mitophagy and mitochondrial biogenesis. BNIP3, NIX, ULK1, p62 and LC3 mRNA levels are increased by TH (Sinha and Yen, 2016). Additionally, activation of AMPK contributes to NAFLD reduction through mitophagy (Smith et al., 2016). Of course, there are active ongoing researches to show the roles of mitophagy in the pathogenesis in other diseases as well.


Failure in the removal of dysfunctional mitochondria induces cellular stress and is linked to human diseases. The function of mitophagy-regulating proteins depends on the tissues and the stimuli they are exposed to. Many LC3 adaptors and receptors were originally reported to function independently of Parkin. However, some of them, such as NIX, participate in Parkin-mediated mitophagy (Gao et al., 2015). NDP52, FUNDC1, BCL2L13, FKBP8 and TBC1D15 are also Parkin substrates under certain conditions (Sarraf et al., 2013). Importantly, mitochondrial dynamics and mitophagy affect each other to maintain the quality of mitochondria. Here again, mitochondrial dynamic factors, such as Miro 1 and 2, Drp1 and FIS1 are also Parkin substrates (Sarraf et al., 2013). Therefore, future studies on mitophagy need also to consider the molecular connection among proteins involved in mitophagy, and among proteins involved in mitophagy and mitochondrial dynamics.

Article information

Mol. Cells.Jan 31, 2018; 41(1): 18-26.
Published online 2018-01-23. doi:  10.14348/molcells.2018.2277
<a href=";db=PubMed&amp;term=Seung-Min+Yoo">Seung-Min Yoo</a>, and <a href=";db=PubMed&amp;term=Yong-Keun+Jung">Yong-Keun Jung</a>
Global Research Laboratory, School of Biological Sciences, Seoul National University, Seoul 08826, Korea
Received October 27, 2017; Accepted November 23, 2017.
Articles from Mol. Cells are provided here courtesy of Mol. Cells


  • Anton, Z, Landajuela, A, Hervas, JH, Montes, LR, Hernandez-Tiedra, S, Velasco, G, Goni, FM, and Alonso, A (2016). Human Atg8-cardiolipin interactions in mitophagy: Specific properties of LC3B, GABARAPL2 and GABARAP. Autophagy. 12, 2386-2403.
  • Ashrafi, G, Schlehe, JS, LaVoie, MJ, and Schwarz, TL (2014). Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J Cell Biol. 206, 655-670.
  • Ban, T, Ishihara, T, Kohno, H, Saita, S, Ichimura, A, Maenaka, K, Oka, T, Mihara, K, and Ishihara, N (2017). Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin. Nat Cell Biol. 19, 856-863.
  • Bhujabal, Z, Birgisdottir, AB, Sjottem, E, Brenne, HB, Overvatn, A, Habisov, S, Kirkin, V, Lamark, T, and Johansen, T (2017). FKBP8 recruits LC3A to mediate Parkin-independent mitophagy. EMBO Rep. 18, 947-961.
  • Bingol, B, Tea, JS, Phu, L, Reichelt, M, Bakalarski, CE, Song, Q, Foreman, O, Kirkpatrick, DS, and Sheng, M (2014). The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature. 510, 370-375.
  • Bragoszewski, P, Turek, M, and Chacinska, A (2017). Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system. Open Biol. , 7.
  • Bravo-San Pedro, JM, Kroemer, G, and Galluzzi, L (2017). Autophagy and mitophagy in cardiovascular disease. Circ Res. 120, 1812-1824.
  • Cenini, G, and Voos, W (2016). Role of mitochondrial protein quality control in oxidative stress-induced neurodegenerative diseases. Curr Alzheimer Res. 13, 164-173.
  • Chan, NC, Salazar, AM, Pham, AH, Sweredoski, MJ, Kolawa, NJ, Graham, RL, Hess, S, and Chan, DC (2011). Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet. 20, 1726-1737.
  • Chen, G, Han, Z, Feng, D, Chen, Y, Chen, L, Wu, H, Huang, L, Zhou, C, Cai, X, and Fu, C (2014). A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy. Mol Cell. 54, 362-377.
  • Chen, Z, Liu, L, Cheng, Q, Li, Y, Wu, H, Zhang, W, Wang, Y, Sehgal, SA, Siraj, S, and Wang, X (2017). Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy. EMBO Rep. 18, 495-509.
  • Chu, CT, Ji, J, Dagda, RK, Jiang, JF, Tyurina, YY, Kapralov, AA, Tyurin, VA, Yanamala, N, Shrivastava, IH, and Mohammadyani, D (2013). Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol. 15, 1197.
  • Cloonan, SM, and Choi, AM (2016). Mitochondria in lung disease. J Clin Invest. 126, 809-820.
  • Drake, LE, Springer, MZ, Poole, LP, Kim, CJ, and Macleod, KF (2017). Expanding perspectives on the significance of mitophagy in cancer. Semin Cancer Biol. 47, 110-124.
  • Esteban-Martinez, L, Sierra-Filardi, E, McGreal, RS, Salazar-Roa, M, Marino, G, Seco, E, Durand, S, Enot, D, Grana, O, and Malumbres, M (2017). Programmed mitophagy is essential for the glycolytic switch during cell differentiation. EMBO J. 36, 1688-1706.
  • Galluzzi, L, Kepp, O, Trojel-Hansen, C, and Kroemer, G (2012). Mitochondrial control of cellular life, stress, and death. Circ Res. 111, 1198-1207.
  • Galluzzi, L, Baehrecke, EH, Ballabio, A, Boya, P, Bravo-San Pedro, JM, Cecconi, F, Choi, AM, Chu, CT, Codogno, P, and Colombo, MI (2017). Molecular definitions of autophagy and related processes. EMBO J. 36, 1811-1836.
  • Gao, F, Chen, D, Si, JM, Hu, QS, Qin, ZH, Fang, M, and Wang, GH (2015). The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1/PARK2 pathway. Hum Mol Genet. 24, 2528-2538.
  • Gottlieb, RA, and Stotland, A (2015). MitoTimer: a novel protein for monitoring mitochondrial turnover in the heart. J Mol Med (Berl). 93, 271-278.
  • Hammerling, BC, and Gustafsson, AB (2014). Mitochondrial quality control in the myocardium: cooperation between protein degradation and mitophagy. J Mol Cell Cardiol. 75, 122-130.
  • Hanna, RA, Quinsay, MN, Orogo, AM, Giang, K, Rikka, S, and Gustafsson, AB (2012). Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem. 287, 19094-19104.
  • Heo, JM, Ordureau, A, Paulo, JA, Rinehart, J, and Harper, JW (2015). The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell. 60, 7-20.
  • Hirota, Y, Yamashita, S, Kurihara, Y, Jin, XL, Aihara, M, Saigusa, T, Kang, DC, and Kanki, T (2015). Mitophagy is primarily due to alternative autophagy and requires the MAPK1 and MAPK14 signaling pathways. Autophagy. 11, 332-343.
  • Landes, T, Emorine, LJ, Courilleau, D, Rojo, M, Belenguer, P, and Arnaune-Pelloquin, L (2010). The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. EMBO Rep. 11, 459-465.
  • Lazarou, M (2015). Keeping the immune system in check: a role for mitophagy. Immunol Cell Biol. 93, 3-10.
  • Lazarou, M, Sliter, DA, Kane, LA, Sarraf, SA, Wang, C, Burman, JL, Sideris, DP, Fogel, AI, and Youle, RJ (2015). The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 524, 309-314.
  • Lee, Y, Lee, HY, Hanna, RA, and Gustafsson, AB (2011). Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am J Physiol-Heart C. 301, H1924-H1931.
  • Lemasters, JJ (2014). Variants of mitochondrial autophagy: Types 1 and 2 mitophagy and micromitophagy (Type 3). Redox Biol. 2, 749-754.
  • Liu, L, Feng, D, Chen, G, Chen, M, Zheng, Q, Song, P, Ma, Q, Zhu, C, Wang, R, and Qi, W (2012). Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 14, 177-185.
  • Magrane, J, Cortez, C, Gan, WB, and Manfredi, G (2014). Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet. 23, 1413-1424.
  • Mao, K, Wang, K, Zhao, M, Xu, T, and Klionsky, DJ (2011). Two MAPK-signaling pathways are required for mitophagy in Saccharomyces cerevisiae. J Cell Biol. 193, 755-767.
  • Martin-Maestro, P, Gargini, R, Perry, G, Avila, J, and Garcia-Escudero, V (2016). PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer’s disease. Hum Mol Genet. 25, 792-806.
  • Martinez-Vicente, M, Talloczy, Z, Wong, E, Tang, GM, Koga, H, Kaushik, S, de Vries, R, Arias, E, Harris, S, and Sulzer, D (2010). Cargo recognition failure is responsible for inefficient autophagy in Huntington’s disease. Nat Neurosci. 13, 567.
  • Matsuda, N, Sato, S, Shiba, K, Okatsu, K, Saisho, K, Gautier, CA, Sou, YS, Saiki, S, Kawajiri, S, and Sato, F (2010). PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol. 189, 211-221.
  • Matsumoto, G, Shimogori, T, Hattori, N, and Nukina, N (2015). TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet. 24, 4429-4442.
  • Merkwirth, C, Dargazanli, S, Tatsuta, T, Geimer, S, Lower, B, Wunderlich, FT, von Kleist-Retzow, JC, Waisman, A, Westermann, B, and Langer, T (2008). Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Gene Dev. 22, 476-488.
  • Miettinen, TP, and Björklund, M (2017). Mitochondrial Function and Cell Size: An Allometric Relationship. Trends Cell Biol. 27, 393-402.
  • Mizumura, K, Cloonan, SM, Nakahira, K, Bhashyam, AR, Cervo, M, Kitada, T, Glass, K, Owen, CA, Mahmood, A, and Washko, GR (2014). Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J Clin Invest. 124, 3987-4003.
  • Moore, AS, and Holzbaur, EL (2016). Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci USA . 113, E3349-3358.
  • Moore, AS, and Holzbaur, EL (2016). Spatiotemporal dynamics of autophagy receptors in selective mitophagy. Autophagy. 12, 1956-1957.
  • Murakawa, T, Yamaguchi, O, Hashimoto, A, Hikoso, S, Takeda, T, Oka, T, Yasui, H, Ueda, H, Akazawa, Y, and Nakayama, H (2015). Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation. Nat Commun. 6, 7527.
  • Nah, J, Yuan, J, and Jung, YK (2015). Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol Cells. 38, 381-389.
  • Narendra, D, Tanaka, A, Suen, DF, and Youle, RJ (2008). Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 183, 795-803.
  • Nguyen, TN, Padman, BS, and Lazarou, M (2016). Deciphering the Molecular Signals of PINK1/Parkin Mitophagy. Trends Cell Biol. 26, 733-744.
  • Novak, I, Kirkin, V, McEwan, DG, Zhang, J, Wild, P, Rozenknop, A, Rogov, V, Lohr, F, Popovic, D, and Occhipinti, A (2010). Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 11, 45-51.
  • Parikh, SM, Yang, Y, He, LY, Tang, CY, Zhan, M, and Dong, Z (2015). Mitochondrial Function and Disturbances in the Septic Kidney. Semin Nephrol. 35, 108-119.
  • Park, S, Choi, SG, Yoo, SM, Nah, J, Jeong, E, Kim, H, and Jung, YK (2015). Pyruvate stimulates mitophagy via PINK1 stabilization. Cell Signal. 27, 1824-1830.
  • Park, S, Choi, SG, Yoo, SM, Son, JH, and Jung, YK (2014). Choline dehydrogenase interacts with SQSTM1/p62 to recruit LC3 and stimulate mitophagy. Autophagy. 10, 1906-1920.
  • Pickrell, AM, and Youle, RJ (2015). The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron. 85, 257-273.
  • Rambold, AS, and Pearce, EL (2017). Mitochondrial dynamics at the interface of immune cell metabolism and function. Trends Immunol. , .
  • Richter, B, Sliter, DA, Herhaus, L, Stolz, A, Wang, CX, Beli, P, Zaffagnini, G, Wild, P, Martens, S, and Wagner, SA (2016). Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci USA. 113, 4039-4044.
  • Rodolfo, C, Campello, S, and Cecconi, F (2017). Mitophagy in neurodegenerative diseases. Neurochem Int. , .
  • Rojansky, R, Cha, MY, and Chan, DC (2016). Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1. Elife. 5, .
  • Saita, S, Shirane, M, and Nakayama, KI (2013). Selective escape of proteins from the mitochondria during mitophagy. Nat Commun. 4, 1410.
  • Sandoval, H, Thiagarajan, P, Dasgupta, SK, Schumacher, A, Prchal, JT, Chen, M, and Wang, J (2008). Essential role for Nix in autophagic maturation of erythroid cells. Nature. 454, 232-235.
  • Sarraf, SA, Raman, M, Guarani-Pereira, V, Sowa, ME, Huttlin, EL, Gygi, SP, and Harper, JW (2013). Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 496, 372-376.
  • Scheibye-Knudsen, M, Fang, EF, Croteau, DL, Wilson, DM, and Bohr, VA (2015). Protecting the mitochondrial powerhouse. Trends Cell Biol. 25, 158-170.
  • Shi, RY, Zhu, SH, Li, V, Gibson, SB, Xu, XS, and Kong, JM (2014). BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci Ther. 20, 1045-1055.
  • Shirihai, OS, Song, MS, and Dorn, GW (2015). How mitochondrial dynamism orchestrates mitophagy. Circ Res. 116, 1835-1849.
  • Sinha, RA, and Yen, PM (2016). Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD. Cell Biosci. 6, .
  • Smith, BK, Marcinko, K, Desjardins, EM, Lally, JS, Ford, RJ, and Steinberg, GR (2016). Treatment of nonalcoholic fatty liver disease: role of AMPK. Am J Physiol Endocrinol Metab. 311, E730-E740.
  • Sowter, HM, Ratcliffe, PJ, Watson, P, Greenberg, AH, and Harris, AL (2001). HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61, 6669-6673.
  • Suliman, HB, and Piantadosi, CA (2016). Mitochondrial quality control as a therapeutic target. Pharmacol Rev. 68, 20-48.
  • Suomalainen, A, and Battersby, BJ (2017). Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol. , .
  • Szargel, R, Shani, V, Abd Elghani, F, Mekies, LN, Liani, E, Rott, R, and Engelender, S (2016). The PINK1, synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway. Hum Mol Genet. 25, 3476-3490.
  • Tanaka, A, Cleland, MM, Xu, S, Narendra, DP, Suen, DF, Karbowski, M, and Youle, RJ (2010). Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol. 191, 1367-1380.
  • Trotta, AP, and Chipuk, JE (2017). Mitochondrial dynamics as regulators of cancer biology. Cell Mol Life Sci. 74, 1999-2017.
  • Vazquez-Martin, A, Van den Haute, C, Cufi, S, Corominas-Faja, B, Cuyas, E, Lopez-Bonet, E, Rodriguez-Gallego, E, Fernandez-Arroyo, S, Joven, J, and Baekelandt, V (2016). Mitophagy-driven mitochondrial rejuvenation regulates stem cell fate. Aging (Albany NY). 8, 1330-1352.
  • Vazquez, F, Lim, JH, Chim, H, Bhalla, K, Girnun, G, Pierce, K, Clish, CB, Granter, SR, Widlund, HR, and Spiegelman, BM (2013). PGC1 alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell. 23, 287-301.
  • Wai, T, and Langer, T (2016). Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab. 27, 105-117.
  • Wang, CW, and Klionsky, DJ (2003). The molecular mechanism of autophagy. Mol Med. 9, 65-76.
  • Wei, YJ, Chiang, WC, Sumpter, R, Mishra, P, and Levine, B (2017). Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. Cell. 168, 224-238.
  • Wong, YC, and Holzbaur, ELF (2014). The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J Neurosci. 34, 1293-1305.
  • Wrighton, KH (2016). Metabolism: Mitophagy turns beige adipocytes white. Nat Rev Mol Cell Biol. 17, 607.
  • Wu, WX, Lin, CX, Wu, K, Jiang, L, Wang, XJ, Li, W, Zhuang, HX, Zhang, XL, Chen, H, and Li, SP (2016). FUNDC1 regulates mitochondrial dynamics at the ER-mitochondrial contact site under hypoxic conditions. EMBO J. 35, 1368-1384.
  • Yamano, K, Fogel, AI, Wang, C, van der Bliek, AM, and Youle, RJ (2014). Mitochondrial Rab GAPs govern autophagosome biogenesis during mitophagy. Elife. 3, e01612.
  • Yamashita, S, and Kanki, T (2017). How autophagy eats large mitochondria: Autophagosome formation coupled with mitochondrial fragmentation. Autophagy. 13, 980-981.
  • Ye, X, Sun, X, Starovoytov, V, and Cai, Q (2015). Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer’s disease patient brains. Hum Mol Genet. 24, 2938-2951.
  • Yuan, Y, Zheng, Y, Zhang, X, Chen, Y, Wu, X, Wu, J, Shen, Z, Jiang, L, Wang, L, and Yang, W (2017). BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2. Autophagy. 13, 1754-1766.
  • Zhang, T, Xue, L, Li, L, Tang, C, Wan, Z, Wang, R, Tan, J, Tan, Y, Han, H, and Tian, R (2016). BNIP3 Protein Suppresses PINK1 Kinase Proteolytic Cleavage to Promote Mitophagy. J Biol Chem. 291, 21616-21629.
  • Zhang, W, Ren, H, Xu, C, Zhu, C, Wu, H, Liu, D, Wang, J, Liu, L, Li, W, and Ma, Q (2016). Hypoxic mitophagy regulates mitochondrial quality and platelet activation and determines severity of I/R heart injury. Elife. 5, .
  • Zhong, Z, Umemura, A, Sanchez-Lopez, E, Liang, S, Shalapour, S, Wong, J, He, F, Boassa, D, Perkins, G, and Ali, SR (2016). NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria. Cell. 164, 896-910.
  • Zhou, H, Zhu, P, Guo, J, Hu, N, Wang, S, Li, D, Hu, S, Ren, J, Cao, F, and Chen, Y (2017). Ripk3 induces mitochondrial apoptosis via inhibition of FUNDC1 mitophagy in cardiac IR injury. Redox Biol. 13, 498-507.
  • Zhu, Y, Massen, S, Terenzio, M, Lang, V, Chen-Lindner, S, Eils, R, Novak, I, Dikic, I, Hamacher-Brady, A, and Brady, NR (2013). Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J Biol Chem. 288, 1099-1113.

Figure 1

Figure 2